Tag - pharmaceuticals

 
 

PHARMACEUTICALS

Japan Times
WORLD / Science & Health
Jul 13, 2023
First over-the-counter birth control pill approved by U.S. regulators
The decision widens access to the drug by removing substantial barriers to obtaining oral contraception, such as inability to get a doctor’s appointment.
Japan Times
JAPAN / Science & Health / FOCUS
Jul 12, 2023
Challenges persist as scandals plague Japan’s generic drug push
The aftermath of a series of manufacturing scandals is leading to shortages of the more affordable alternatives to brand-name medicine.
Japan Times
BUSINESS / Companies
Jul 11, 2023
Eisai appoints CEO’s son to lead global Alzheimer drug program
Eisai's former global Alzheimer drug program officer, who led the push for U.S. approval of breakthrough medicine Leqembi, will retire at the end of the month.
Japan Times
WORLD / Science & Health
Jul 7, 2023
Eisai Alzheimer's drug gets full U.S. approval, widening access to the therapy
The broader clearance from the Food and Drug Administration marks a milestone for treatment of the dementia that afflicts some 6 million Americans.
Japan Times
BUSINESS
Jul 6, 2023
Moderna signs deal with Shanghai to make mRNA vaccines for Chinese market
The Massachusetts-based company will work with local government to conduct clinical trials and apply to bring products to market as well as to produce them in China.
Japan Times
JAPAN / Science & Health / FOCUS
Jul 4, 2023
Expectations grow for Alzheimer's drug in Japan, but hurdles remain
Lecanemab could be approved in the country as early as fall, but more specialist doctors and a patient screening system would be needed for widespread use.
Japan Times
COMMENTARY / World
Jun 28, 2023
Eli Lilly’s new weight-loss drug is even better than Ozempic
When it comes to manipulating the human metabolism, we’re entering entirely new territory with new drugs.
Japan Times
JAPAN / Science & Health
Jun 27, 2023
Rare cancer drug trials to go online in Japan
The project is aimed at making it easier for patients in the countryside to join clinical trials and reduce their economic burden.
Japan Times
WORLD / Science & Health
Jun 19, 2023
New Eisai and Biogen Alzheimer drug faces hurdles in Europe
Some doctors said its effect on the disease may not be clinically meaningful enough when weighed against the risk of brain swelling, its likely high price.
Japan Times
JAPAN / Science & Health
Jun 13, 2023
Japan panel weighs making morning-after pill available over the counter
Under the current policy, a visit to a medical institution and a prescription are required to purchase a morning-after pill.
Japan Times
WORLD / Politics
Jun 8, 2023
U.S. takes aim at China over Latin America trade tactics and fentanyl role
China has denounced U.S. sanctions on Chinese firms and individuals over their alleged involvement in the fentanyl trade and has accused Washington of trying to deflect blame.
Japan Times
BUSINESS / Companies
Jun 7, 2023
AstraZeneca’s Japan partner to go solo on future cancer drugs
Daiichi Sankyo is expanding its sales and development staff overseas, aiming to boost production capacity so that it can handle its cancer drugs business entirely on its own.
Japan Times
WORLD / Science & Health
Jun 6, 2023
Cancer vaccines poised to unlock 'new treatment paradigm' with Merck-Moderna data
Scientists have been chasing the dream of vaccines to treat cancer for decades with few successes.
Japan Times
WORLD / Science & Health
Jun 3, 2023
Breast cancer drug shown to reduce recurrence risk
Even when the disease is caught early, breast cancer recurrence is relatively common — and for survivors, the prospect can be daunting.
Japan Times
BUSINESS
Jun 1, 2023
Contaminated drugs, shredded papers: U.S. FDA uncovers failures in India pharma factories
Authorities have suspended the licenses of more than a dozen unlisted drugmakers in the wake of dozens of cough syrup deaths.
Japan Times
BUSINESS
Jun 1, 2023
Obesity and Alzheimer's news makes Eli Lilly world’s most valuable drugmaker
An 8.5% gain in May for Eli Lilly lifted its shares to a record high, while displaced Johnson & Johnson slumped 5.3% during the month.
Japan Times
WORLD
May 30, 2023
Critics say pandemic treaty text is 'step backward'
Changes to the preliminary negotiating text are seen as weakening language on preventing the rampant inequality seen in access to vaccines during the COVID-19 pandemic.
Japan Times
JAPAN / Science & Health
May 29, 2023
Doctors in Japan turn to crowdfunding to continue stroke treatment trial
The trial for the drug to treat acute stroke sufferers has hit a snag due to surging import costs, with the price of a vial going from ¥300,000 to ¥1.6 million.
Japan Times
COMMENTARY / World
May 22, 2023
Xylazine spreads faster than U.S. officials can act
The U.S. needs better ways of tracking illicit xylazine, a sedative that’s especially dangerous when mixed with fentanyl.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?